New Stent Retriever, VERSI System for AIS
Efficacy and Safety of VERSI System for Acute Ischemic Stroke
1 other identifier
interventional
10
1 country
1
Brief Summary
To confirm efficacy and safety of VERSI system for acute ischemic stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2017
CompletedFirst Submitted
Initial submission to the registry
November 11, 2017
CompletedFirst Posted
Study publicly available on registry
December 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedOctober 15, 2019
October 1, 2019
6 months
November 11, 2017
October 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of treatment-related severe adverse event
symptomatic intracranial hemorrhage
within 24 hours after procedure
Secondary Outcomes (5)
recovery to independent life {modified Rankin score of 2 or less]
90days after procedure
all intracralnial hemorrhage
within 24 hours after procedure
acceptable clinical outcome
90days after procedure
Severe adverse event related to device
within 24 hours after procedure
recanalization ability of device
immediatry after procedure
Study Arms (1)
thrombectomy
EXPERIMENTALthrombectomy by Versi system
Interventions
Eligibility Criteria
You may qualify if:
- onset to treat within 8 hours
- NIHSS 8 or more
- ASPECTS 5 or more
- Target vessel is ICA, MCA, VA, BA, PCA
- non-eligible or failed IV rt-PA
You may not qualify if:
- known hemorrhagic tendency
- arterial dissection, vasculitis
- allergy for contrast media
- other inappropriate condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kobe City General Hospital
Kobe, Hyōgo, Japan
Related Publications (1)
Sakai N, Imamura H, Adachi H, Tani S, Tokunaga S, Funatsu T, Suzuki K, Adachi H, Sasaki N, Kawabata S, Akiyama R, Horiuchi K, Ohara N, Kono T, Fujiwara S, Kaneko N, Tateshima S. First-in-man experience of the Versi Retriever in acute ischemic stroke. J Neurointerv Surg. 2019 Mar;11(3):296-299. doi: 10.1136/neurintsurg-2018-014040. Epub 2018 Sep 27.
PMID: 30262657DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nobuyuki Sakai, MD DMSc
Kobe City Medical Center General Hospital, Kobe, Japan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Neurosurgery
Study Record Dates
First Submitted
November 11, 2017
First Posted
December 8, 2017
Study Start
September 21, 2017
Primary Completion
March 31, 2018
Study Completion
March 31, 2019
Last Updated
October 15, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share